Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept

Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi Zhang, Yinfen Hou, Xiao Cao, Rongrong Zhang, Yinping Liu, Chenghua Wei, Changfan Wu, Lixin Mei, Pengfei Zhang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/b805cbff053144d38333f10fb51a1f40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b805cbff053144d38333f10fb51a1f40
record_format dspace
spelling oai:doaj.org-article:b805cbff053144d38333f10fb51a1f402021-11-28T12:42:20ZPredictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept10.1186/s12886-021-02174-01471-2415https://doaj.org/article/b805cbff053144d38333f10fb51a1f402021-11-01T00:00:00Zhttps://doi.org/10.1186/s12886-021-02174-0https://doaj.org/toc/1471-2415Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patients with different OCT measures at 6 months follow-up to identify the factors that are most strongly correlated with the best-corrected visual acuity (BCVA) post-treatment in CRVO-ME patients treated with conbercept. Purpose To evaluate the effectiveness of intravitreal conbercept injections for the treatment of CRVO-ME and to determine the major predictors of best-corrected visual acuity (BCVA) post-treatment. Methods A retrospective study methodology was used. Twenty-six eyes from 26 patients with CRVO-ME were enrolled in the study. After an initial intravitreal injection of conbercept (0.5 mg/0.05 ml), monthly injections for up to 6 months were given following a 1 + PRN (pro re nata) regimen. Data collected at monthly intervals included measurements of the logMAR BCVA, central subfield thickness (CST), macular volume (MV), photoreceptor layer thickness (PLT), outer nuclear layer thickness (ONLT), and the disrupted ellipsoid zone (DEZ). The correlation between BCVA, before and after injections, and each of CST, MV, PLT, ONLT, DEZ was analyzed. Results The logMAR BCVA in months 3 and 6 post-injection was significantly improved relative to the baseline. In this same period the CST, MV, PLT, ONLT and DEZ were also significantly improved relative to the baseline. There was a negative correlation between PLT and logMAR BCVA at months 3 and 6 after treatment (r = − 0.549, P < 0.001; r = − 0.087, P < 0.001). Conclusion Intravitreal injection of conbercept is an effective treatment for CRVO-ME. With 6 months of follow-up, logMAR BCVA and CST, MV, PLT, ONLT, DEZ improved. PLT was negatively correlated with the visual function in CRVO-ME patients after conbercept treatment, which may be a predictor of vision recovery in patients with CRVO-ME.Qi ZhangYinfen HouXiao CaoRongrong ZhangYinping LiuChenghua WeiChangfan WuLixin MeiPengfei ZhangBMCarticleCRVO-MEConberceptBest corrected visual acuity, predictive factorOphthalmologyRE1-994ENBMC Ophthalmology, Vol 21, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic CRVO-ME
Conbercept
Best corrected visual acuity, predictive factor
Ophthalmology
RE1-994
spellingShingle CRVO-ME
Conbercept
Best corrected visual acuity, predictive factor
Ophthalmology
RE1-994
Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
description Abstract Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been seen. We collected 26 CRVO-ME patients with different OCT measures at 6 months follow-up to identify the factors that are most strongly correlated with the best-corrected visual acuity (BCVA) post-treatment in CRVO-ME patients treated with conbercept. Purpose To evaluate the effectiveness of intravitreal conbercept injections for the treatment of CRVO-ME and to determine the major predictors of best-corrected visual acuity (BCVA) post-treatment. Methods A retrospective study methodology was used. Twenty-six eyes from 26 patients with CRVO-ME were enrolled in the study. After an initial intravitreal injection of conbercept (0.5 mg/0.05 ml), monthly injections for up to 6 months were given following a 1 + PRN (pro re nata) regimen. Data collected at monthly intervals included measurements of the logMAR BCVA, central subfield thickness (CST), macular volume (MV), photoreceptor layer thickness (PLT), outer nuclear layer thickness (ONLT), and the disrupted ellipsoid zone (DEZ). The correlation between BCVA, before and after injections, and each of CST, MV, PLT, ONLT, DEZ was analyzed. Results The logMAR BCVA in months 3 and 6 post-injection was significantly improved relative to the baseline. In this same period the CST, MV, PLT, ONLT and DEZ were also significantly improved relative to the baseline. There was a negative correlation between PLT and logMAR BCVA at months 3 and 6 after treatment (r = − 0.549, P < 0.001; r = − 0.087, P < 0.001). Conclusion Intravitreal injection of conbercept is an effective treatment for CRVO-ME. With 6 months of follow-up, logMAR BCVA and CST, MV, PLT, ONLT, DEZ improved. PLT was negatively correlated with the visual function in CRVO-ME patients after conbercept treatment, which may be a predictor of vision recovery in patients with CRVO-ME.
format article
author Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
author_facet Qi Zhang
Yinfen Hou
Xiao Cao
Rongrong Zhang
Yinping Liu
Chenghua Wei
Changfan Wu
Lixin Mei
Pengfei Zhang
author_sort Qi Zhang
title Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_short Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_full Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_fullStr Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_full_unstemmed Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
title_sort predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with conbercept
publisher BMC
publishDate 2021
url https://doaj.org/article/b805cbff053144d38333f10fb51a1f40
work_keys_str_mv AT qizhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT yinfenhou predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT xiaocao predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT rongrongzhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT yinpingliu predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT chenghuawei predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT changfanwu predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT lixinmei predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
AT pengfeizhang predictorsofvisualrecoveryinpatientswithmacularedemasecondarytocentralretinalveinocclusionaftertreatmentwithconbercept
_version_ 1718407853856784384